Investigational Drug Information for Sorivudine
✉ Email this page to a colleague
What is the development status for investigational drug Sorivudine?
Sorivudine is an investigational drug.
There have been 6 clinical trials for Sorivudine.
The most recent clinical trial was a Phase 3 trial.
The most common disease conditions in clinical trials are Chickenpox, Rectal Neoplasms, and HIV Infections. The leading clinical trial sponsors are Bristol-Myers Squibb, Genentech, Inc., and M.D. Anderson Cancer Center.
Summary for Sorivudine
US Patents | 0 |
International Patents | 0 |
US Patent Applications | 1,604 |
WIPO Patent Applications | 782 |
Japanese Patent Applications | 183 |
Clinical Trial Progress | Phase 3 (1969-12-31) |
Vendors | 29 |
Recent Clinical Trials for Sorivudine
Title | Sponsor | Phase |
---|---|---|
Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles) | aRigen Pharmaceuticals, Inc. | Phase 2 |
Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer | Genentech, Inc. | Phase 1 |
Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer | M.D. Anderson Cancer Center | Phase 1 |
Clinical Trial Summary for Sorivudine
Top disease conditions for Sorivudine
Top clinical trial sponsors for Sorivudine
US Patents for Sorivudine
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |